Physician profile
Steven P Hand
NPI 1417092362
$2,899.38
in general payments reported to CMS, 2019-2025
29 companies · $1,297 in 2025
The $1,297 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2020: $242 · 2021: $299 · 2022: $235 · 2023: $208 · 2024: $182 · 2025: $1,297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,001 · Food and Beverage: $686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,000.69 |
| Food and Beverage | $685.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $1,000.69 | 2025 | |
| Abbott Laboratories | $185.25 | 2019-2021 | |
| Smith+Nephew, INC. | $184.74 | 2019-2024 | Pico, Grafix Pl |
| Medtronic, INC. | $157.57 | 2025 | Cd Horizon Spinal System |
| Bioventus LLC | $150.26 | 2019-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Ferring Pharmaceuticals INC. | $138.85 | 2019-2024 | Euflexxa |
| Pfizer INC. | $133.92 | 2019-2023 | |
| Endo Pharmaceuticals INC. | $122.91 | 2019-2023 | Xiaflex |
| Depuy Synthes Sales INC. | $109.23 | 2020-2025 | Expedium |
| Endo USA, INC. | $97.23 | 2024-2025 | Xiaflex |
| Zimmer Biomet Holdings, INC. | $73.70 | 2020-2023 | |
| Stryker Corporation | $70.31 | 2019-2023 | Mako |
| Convatec INC. | $66.19 | 2019-2022 | |
| Pacira Therapeutics, INC. | $54.30 | 2019-2020 | |
| Dynasplint Systems INC. | $51.61 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $37.85 | 2019 | |
| Horizon Therapeutics Plc | $36.42 | 2020-2022 | |
| Integra Lifesciences Corporation | $33.93 | 2021-2023 | Tenoglide |
| Sanofi-Aventis U.S. LLC | $27.11 | 2019 | |
| Si-Bone, INC. | $23.23 | 2024 | |
| Tactile Systems Technology INC | $20.08 | 2024 | Entre Plus, Flexitouch Plus |
| Heron Therapeutics, INC. | $19.98 | 2023 | Zynrelef |
| E.R. Squibb & Sons, L.L.C. | $18.25 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.72 | 2023 | Seglentis |
| Orthofix Medical, INC. | $15.68 | 2019 | |
| Medtronic USA, INC. | $14.72 | 2019 | |
| Sanara Medtech INC. | $14.71 | 2020 | |
| Davol INC. | $12.35 | 2021 | |
| Heraeus Medical, LLC. | $11.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Hand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.